7-21852629-A-G

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2

The NM_001277115.2(DNAH11):​c.11059A>G​(p.Lys3687Glu) variant causes a missense, splice region change. The variant allele was found at a frequency of 0.00218 in 1,582,704 control chromosomes in the GnomAD database, including 71 homozygotes. In-silico tool predicts a benign outcome for this variant. 3/3 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.011 ( 41 hom., cov: 32)
Exomes 𝑓: 0.0012 ( 30 hom. )

Consequence

DNAH11
NM_001277115.2 missense, splice_region

Scores

5
2
10
Splicing: ADA: 0.009570
2

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:5

Conservation

PhyloP100: 5.24

Publications

3 publications found
Variant links:
Genes affected
DNAH11 (HGNC:2942): (dynein axonemal heavy chain 11) This gene encodes a ciliary outer dynein arm protein and is a member of the dynein heavy chain family. It is a microtubule-dependent motor ATPase and has been reported to be involved in the movement of respiratory cilia. Mutations in this gene have been implicated in causing Kartagener Syndrome (a combination of situs inversus totalis and Primary Ciliary Dyskinesia (PCD), also called Immotile Cilia Syndrome 1 (ICS1)) and male sterility. [provided by RefSeq, Mar 2013]
DNAH11 Gene-Disease associations (from GenCC):
  • primary ciliary dyskinesia 7
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: PanelApp Australia, Laboratory for Molecular Medicine, Labcorp Genetics (formerly Invitae), ClinGen
  • primary ciliary dyskinesia
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.008550942).
BP6
Variant 7-21852629-A-G is Benign according to our data. Variant chr7-21852629-A-G is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 257849.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population afr. GnomAd4 allele frequency = 0.0114 (1737/152266) while in subpopulation AFR AF = 0.0391 (1623/41550). AF 95% confidence interval is 0.0375. There are 41 homozygotes in GnomAd4. There are 805 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 41 AR,AD gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
DNAH11NM_001277115.2 linkc.11059A>G p.Lys3687Glu missense_variant, splice_region_variant Exon 67 of 82 ENST00000409508.8 NP_001264044.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
DNAH11ENST00000409508.8 linkc.11059A>G p.Lys3687Glu missense_variant, splice_region_variant Exon 67 of 82 5 NM_001277115.2 ENSP00000475939.1
DNAH11ENST00000421290.1 linkn.242A>G splice_region_variant, non_coding_transcript_exon_variant Exon 2 of 4 4
DNAH11ENST00000607413.5 linkn.322A>G splice_region_variant, non_coding_transcript_exon_variant Exon 2 of 4 4

Frequencies

GnomAD3 genomes
AF:
0.0114
AC:
1734
AN:
152148
Hom.:
41
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0391
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00471
Gnomad ASJ
AF:
0.00202
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00633
Gnomad NFE
AF:
0.000206
Gnomad OTH
AF:
0.00956
GnomAD2 exomes
AF:
0.00340
AC:
751
AN:
220596
AF XY:
0.00266
show subpopulations
Gnomad AFR exome
AF:
0.0427
Gnomad AMR exome
AF:
0.00203
Gnomad ASJ exome
AF:
0.00334
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.000135
Gnomad OTH exome
AF:
0.00253
GnomAD4 exome
AF:
0.00120
AC:
1719
AN:
1430438
Hom.:
30
Cov.:
33
AF XY:
0.00108
AC XY:
767
AN XY:
709134
show subpopulations
African (AFR)
AF:
0.0418
AC:
1343
AN:
32122
American (AMR)
AF:
0.00253
AC:
98
AN:
38720
Ashkenazi Jewish (ASJ)
AF:
0.00256
AC:
62
AN:
24254
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39402
South Asian (SAS)
AF:
0.0000876
AC:
7
AN:
79952
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
52532
Middle Eastern (MID)
AF:
0.000539
AC:
3
AN:
5562
European-Non Finnish (NFE)
AF:
0.0000491
AC:
54
AN:
1098894
Other (OTH)
AF:
0.00258
AC:
152
AN:
59000
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.482
Heterozygous variant carriers
0
77
154
232
309
386
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
50
100
150
200
250
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0114
AC:
1737
AN:
152266
Hom.:
41
Cov.:
32
AF XY:
0.0108
AC XY:
805
AN XY:
74468
show subpopulations
African (AFR)
AF:
0.0391
AC:
1623
AN:
41550
American (AMR)
AF:
0.00471
AC:
72
AN:
15296
Ashkenazi Jewish (ASJ)
AF:
0.00202
AC:
7
AN:
3468
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5182
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4824
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10610
Middle Eastern (MID)
AF:
0.00340
AC:
1
AN:
294
European-Non Finnish (NFE)
AF:
0.000206
AC:
14
AN:
68018
Other (OTH)
AF:
0.00946
AC:
20
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
78
156
233
311
389
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00389
Hom.:
44
Bravo
AF:
0.0130
ESP6500AA
AF:
0.0342
AC:
138
ESP6500EA
AF:
0.000238
AC:
2
ExAC
AF:
0.00351
AC:
425
Asia WGS
AF:
0.00231
AC:
8
AN:
3478

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:5
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
Sep 24, 2021
GeneDx
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

See Variant Classification Assertion Criteria.

Aug 01, 2024
CeGaT Center for Human Genetics Tuebingen
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

DNAH11: BP4, BS1, BS2

not specified Benign:1
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Primary ciliary dyskinesia 7 Benign:1
Oct 18, 2024
ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Primary ciliary dyskinesia Benign:1
Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.20
BayesDel_addAF
Benign
-0.30
T
BayesDel_noAF
Benign
-0.17
CADD
Benign
20
DANN
Uncertain
1.0
DEOGEN2
Benign
0.0
.;.;T
Eigen
Pathogenic
0.81
Eigen_PC
Uncertain
0.60
FATHMM_MKL
Pathogenic
0.99
D
LIST_S2
Pathogenic
0.98
D;D;D
MetaRNN
Benign
0.0086
T;T;T
MetaSVM
Benign
-1.0
T
MutationAssessor
Benign
0.0
.;.;.
PhyloP100
5.2
PrimateAI
Benign
0.46
T
PROVEAN
Benign
0.0
.;D;.
REVEL
Benign
0.0
Sift
Pathogenic
0.0
.;D;.
Sift4G
Pathogenic
0.0
.;.;.
Vest4
0.54
ClinPred
0.098
T
GERP RS
3.7
Varity_R
0.60
gMVP
0.62
Mutation Taster
=98/2
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
dbscSNV1_ADA
Benign
0.0096
dbscSNV1_RF
Benign
0.084
SpliceAI score (max)
0.090
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs72657402; hg19: chr7-21892247; COSMIC: COSV106466729; API